Malignant Thymus Neoplasm — Trials

Malignant Thymus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

193 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 80
Recruiting: 43
Ph III recruiting: 1
Growth YoY: —
Industry share: 23%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05934084	Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors	recruiting	N/A	552	Fondazione Italiana Linfomi - ETSOTHER	1	Sep 11, 2026	clinicaltrials
NCT06141369	Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)	recruiting	N/A	21	Shanghai Jiao Tong University School of MedicineOTHER	1	Apr 9, 2026	clinicaltrials